Role of the SNK-SPAR pathway in the development of Alzheimer's disease

IUBMB Life

Volumn 62, Issue 3, 2010, Pages 214-221

  Gong, Xiaoyang ^a   Lu, Xiaoguang ^b   Zhan, Libin ^a   Sui, Hua ^a   Qi, Xin ^c   Ji, Zhenghong ^d   Niu, Xinping ^d   Liu, Li ^b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b DALIAN UNIVERSITY   (China)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Dalian Second People's Hospital   (China)

Author keywords

amyloid peptide 1 40; Alzheimer's disease; Dendritic spines; SNK SPAR pathway

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; GUANOSINE TRIPHOSPHATASE; MESSENGER RNA; POLO LIKE KINASE 2; PROTEIN SPAR; RAP PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DENDRITIC SPINE; EXCITOTOXICITY; HIPPOCAMPUS; LEARNING; MALE; MAZE TEST; MEMORY; NONHUMAN; PASSIVE AVOIDANCE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TASK PERFORMANCE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CEREBRAL CORTEX; DENDRITIC SPINES; GTPASE-ACTIVATING PROTEINS; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; PEPTIDE FRAGMENTS; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 77951100396     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.308     Document Type: Article

References (38)

1. Selkoe, D. J. (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
2. Sheng, M., and Kim, M. J. (2002) Postsynaptic signaling and plasticity mechanisms. Science 298, 776-780.
3. Kennedy, M. B. (2000) Signal-processing machines at the postsynaptic density. Science 290, 750-754.
4. Pak, D. T., Yang, S., Rudolph-Correia, S., Kim, E., and Sheng, M. (2001) Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron 31, 289-303. (Pubitemid 32762981)
5. Bartolomeis, A.de, and Fiore, G. (2004) Posrsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: implications for human behavior pathologies. Int. Rev. Neurobiol. 59, 221-254.
6. Pak, D. T., and Sheng, M. (2003) Targeted protein degradation and synapse remodeling by an inducible protein kinase. Science 302, 1368-1373.
7. Wu, L. X., Sun, C. K., and Zhang, Y. M. (2007) Involvement of the Snk-SPAR pathway in glutamate-induced excitotoxicity in cultured hippocampal neurons. Brain. Res 1168, 38-45. (Pubitemid 47320628)
8. Giovannelli, L., Casamenti, F., and Scali, C. (1995) Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. Neuroscience 66, 781-792.
9. (1-42) injections in the rat. Brain. Res. 954, 1-10.
10. Haass, C., and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell. Biol. 8, 101-112.
11. Lacor, P. N., Buniel, M. C., and Klein, W. L. (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 24, 10191-10200.
12. Deshpande, A., Kawai, H., and Metherate, R. (2009) A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. J. Neurosci. 29, 4004-4015.
13. Dekosky, S. T., and Scheff, S. W. (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27, 457-464.
14. Coleman, P., Federoff, H., and Kurlan, R. (2004) A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63, 1155-1162. (Pubitemid 39350010)
15. Walsh, D. M., and Selkoe, D. J. (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193. (Pubitemid 39348839)
16. Klein, W. L. (2006) Synaptic targeting by Ab oligomers (ADDLs) as a basis for memory loss in early Alzheimer's disease. Alzheimers Dement 2, 43-55.
17. Georganopoulou, D. G., Chang, L., and Klein, W. L. (2005) Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 102, 2273-2276.
18. Li, S., Hong, S., and Selkoe, D. J. (2009) Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788-801.
19. Stutzmann, G. E. (2007) The pathogenesis of Alzheimers disease is it a lifelong "calciumopathy?" Neuroscientist 13, 546-559.
20. Zhao, W. Q., De Felice, F. G., and Klein, W. L. (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. J. FASEB. 22, 246-260.
21. De, F., Felice, F. G. D.e, and Klein, W. L. (2008) Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol. Aging 29, 1334-1347.
22. Snyder, E. M., Nong, Y., and Almeida, C. G. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 1051-1058.
23. Hankar, G. M., Li, S., and Selkoe, D. J. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842.
24. Tsai, J., Grutzendler, J., and Duff, K. (2004) Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7, 1181-1183.
25. Le, R., Cruz, L., and Urbanc, B. (2001) Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption. J. Neuropathol. Exp. Neurol. 60, 753-758.
26. Grutzendler, J., Helmin, K., and Tsai, J. (2007) Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Ann. NY Acad. Sci. 1097, 30-39.
27. Spires-Jones, T. L., Meyer-Luehmann, M., and Osetek, J. D. (2007) Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. Am. J. Pathol. 171, 1304-1311.
28. Meyer, G., and Brose, N. (2003) SPARring with spines. Science 302, 1341-1344.
29. Grossman, A. W., Aldridge, G. M., and Weiler, I. J. (2006) Local protein synthesis and spine morphogenesis: fragile X syndrome and beyond. J. Neurosci. 26, 7151-7155.
30. Tada, T., and Sheng, M. (2006) Molecular mechanisms of dendritic spine morphogenesis. Curr. Opin. Neurobiol. 16, 95-101.
31. Spires, T. L., Molnar, Z., and Kind, P. C. (2005) Activity-dependent regulation of synapse and dendritic spine morphology in developing barrel cortex requires phospholipase C-β1 signalling. Cereb. Cortex. 15, 385-393.
32. Hayashi, K., and Shirao, T. (1999) Change in the shape of dendritic spines caused by overexpression of drebrin in cultured cortical neurons. J. Neurosci. 19, 3918-3925. (Pubitemid 29222266)
33. Carlisle, H. J., and Kennedy, M. B. (2005) Spine architecture and synaptic plasticity. Trends. Neurosci. 28, 182-187.
34. Ethell, I., and Pasquale, E. (2005) Molecular mechanisms of dendritic spine development and remodeling. Prog. Neurobiol. 75, 161-205.
35. Matus, A. (2000) Actin-based plasticity in dendritic spines. Science 290, 754-758.
36. Schubert, V., and Dotti, C. G. (2007) Transmitting on actin: synaptic control of dendritic architecture. J. Cell. Sci. 15, 120 (Part 2), 205-212.
37. Fischer, M., Kaech, S., and Wagner, U. (2000) Glutamate receptors regulate actinbased plasticity in dendritic spines. Nat. Neurosci. 3, 887-894.
38. Seeburg, D. P., Pak, D., and Sheng, M. (2005) Polo-like kinases in the nervous system. Oncogene 24, 292-298.